Literature DB >> 26254560

Longitudinal evaluation of hepatitis C viral persistence in HIV-infected patients with spontaneous hepatitis C clearance.

A Rivero-Juarez1, A Caruz2, L M Real3, L Martinez-Dueñas1, F J Marquez2, M Frias1, E Recio3, A Gordon1, J A Pineda3, A Rivero4, A Camacho1.   

Abstract

Hepatitis C virus (HCV) viral persistence in patients with spontaneous viral clearance is controversial. Several studies have shown HCV-RNA in peripheral blood mononuclear cells (PBMCs) and/or liver tissue among patients who have cleared the virus spontaneously, suggesting that viral persistence is a common situation that could involve the entire population studied. Thus, our aim was to evaluate HCV-RNA persistence in PBMCs and hepatocytes in subjects infected with the human immunodeficiency virus (HIV). A total of 1508 patients were prospectively followed and tested for anti-HCV antibodies and HCV-RNA to identify the patients who achieved spontaneous viral clearance. In all of the patients, the persistence of HCV-RNA in PBMCs was evaluated longitudinally during 2 years of follow-up. Fifty-nine patients fulfilled the inclusion/exclusion criteria and were included in the study. HCV-RNA was not detected in the PBMCs at baseline [59 PBMCs samples tested; 0 %; 95 % confidence interval (CI): 0-3.3 %] or during the follow-up (147 PBMCs samples tested; 0 %; 95 % CI: 0-2.02 %). Our study shows that HCV viral persistence is not a frequent occurrence in HIV-infected patients who have spontaneously resolved an HCV infection. Thus, the lack of serum HCV-RNA should continue to be addressed as the standard of healing.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26254560     DOI: 10.1007/s10096-015-2463-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses.

Authors:  Naga Suresh Veerapu; Sukanya Raghuraman; T Jake Liang; Theo Heller; Barbara Rehermann
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

2.  Comparative study between occult hepatitis C virus infection and chronic hepatitis C.

Authors:  M Pardo; J M López-Alcorocho; E Rodríguez-Iñigo; I Castillo; V Carreño
Journal:  J Viral Hepat       Date:  2007-01       Impact factor: 3.728

3.  Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.

Authors:  Inmaculada Castillo; Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Margarita Pardo; Javier Bartolomé; Vicente Carreño
Journal:  Clin Infect Dis       Date:  2006-10-05       Impact factor: 9.079

4.  Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.

Authors:  Vicente Carreño; Margarita Pardo; Juan Manuel López-Alcorocho; Elena Rodríguez-Iñigo; Javier Bartolomé; Inmaculada Castillo
Journal:  J Infect Dis       Date:  2006-05-16       Impact factor: 5.226

Review 5.  Innate immunity and HCV.

Authors:  Markus H Heim
Journal:  J Hepatol       Date:  2012-10-11       Impact factor: 25.083

6.  Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

Authors:  Tram N Q Pham; Sonya A MacParland; Patricia M Mulrooney; Helen Cooksley; Nikolai V Naoumov; Tomasz I Michalak
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

Authors:  Sarah Maylin; Michelle Martinot-Peignoux; Rami Moucari; Nathalie Boyer; Marie-Pierre Ripault; Dominique Cazals-Hatem; Nathalie Giuily; Corinne Castelnau; Ana Carolina Cardoso; Tarik Asselah; Cyrille Féray; Marie Hélène Nicolas-Chanoine; Pierre Bedossa; Patrick Marcellin
Journal:  Gastroenterology       Date:  2008-05-21       Impact factor: 22.682

8.  Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.

Authors:  Flavien Bernardin; Leslie Tobler; Irina Walsh; Joan Dunn Williams; Mike Busch; Eric Delwart
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

9.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

10.  Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection.

Authors:  Matthew Hoare; William T H Gelson; Simon M Rushbrook; Martin D Curran; Tracy Woodall; Nicholas Coleman; Susan E Davies; Graeme J M Alexander
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

View more
  1 in total

1.  Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR.

Authors:  Mario Frías; Antonio Rivero-Juárez; Francisco Téllez; Rosario Palacios; Álvaro Jiménez-Arranz; Juan A Pineda; Dolores Merino; María Amparo Gómez-Vidal; Inés Pérez-Camacho; Ángela Camacho; Antonio Rivero
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.